Posts by Raymond J. March
Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Agribusiness and Applied Economics at North Dakota State University.
Trump Signs More Executive Orders as a Last-Ditch Effort to Lower Drug Prices


It has been over three years since Donald Trump became the 45th President of the United States of America. During his first run for the Oval Office, he vowed to take on drug companies and lower the cost of prescription drugs. With less than one-hundred days until the 2020 presidential election, he has yet…
Read More »

State Mismanagement of Covid-19 Data Continues


Mindy Clark of Sarasota, Florida, drove to a COVID-19 testing site at Manatee Rural Health because she thought she might have contracted the virus. At the drive-thru testing center, she was told to take the test only if she had experienced symptoms. She drove away before being swabbed. Two days later, she received a…
Read More »

Don’t Trust Government to Distribute Covid-19 Drugs


As new Covid-19 cases continue across the U.S., many states are preparing for a potential second wave of outbreaks and reinstated lockdown measures. Arizona hospitals are enacting emergency plans to accommodate a rapid influx of new infections. Florida has ordered bars to stop serving alcohol (after allowing them to reopen less than a month…
Read More »

President Trump’s ‘Operation Warp Speed’ Vaccine Project Might Crash Into Perverse Incentives


This May, President Trump unveiled Operation Warp Speed, a partnership between federal regulatory agencies and private drug producers that aims to develop and distribute a Covid-19 vaccine by January. The president described the project’s lofty goal of achieving a pioneering scientific discovery in record-breaking time as “unlike anything our country has seen since The Manhattan…
Read More »

To Make Drugs More Affordable, President Trump Should Focus on Price Competition


President Trump has tried seemingly everything to lower prescription drug prices. In 2018 alone, he established an international pricing index to prevent overcharging from foreign drug producers, targeted drug rebates between producers and middlemen, and granted Medicare Part D plans more authority to negotiate drug prices. Despite these and other efforts, the prices for thousands of…
Read More »

Are Special Interests Undermining the Quest for a Covid-19 Vaccine?


At the time of peak lockdown, nearly 94 percent of the U.S. population was placed under stay-at-home orders to slow the spread of Covid-19. Currently, every state is working toward ending, or already has ended, their stay-at-home measures. Lifting the lockdown has provided many benefits. Foremost, the U.S. economy climbed out of a severe…
Read More »

Coronavirus Corruption: Bad Incentives and Politics as Usual


Rebeckah Jones worked for the Florida Department of Health’s Geographic Information team. One of her greatest responsibilities was to develop and maintain the Florida Covid-19 Data and Surveillance Dashboard. The dashboard provides Floridians with timely information on the number of COVID-19 cases, hospitalizations, and fatalities at the state and county level. Despite receiving considerable…
Read More »

Keep Government Out of Developing a COVID-19 Vaccine


In late March, California became the first state to issue mandatory “shelter in place” orders. By mid-April, nearly 94 percent of the U.S. population was under order to stay at home. Nearly three months later, millions are still desperate to get back to their lives. Protest rallies held to “reopen the economy” have emerged…
Read More »

More Executive Orders Will Not Fix Healthcare


Draconian measures to “flatten the curve” were implemented to prevent the healthcare sector from becoming overwhelmed with infected patients. Now, as many states reopen for business, it seems relatively few healthcare facilities are overwhelmed. However, much of the healthcare industry is still struggling. Becker Hospital Review finds that more than 250 hospitals are furloughing…
Read More »

Private Enterprise Continues to Flatten the Curve


A few weeks ago, I published an op-ed in The Hill entitled “Trust Private Enterprise to Flatten the Curve.” There I argued that markets, rather than the heavy hand of government, are our best hope to combat COVID-19. Between then and now, markets have continued to provide patients and healthcare professionals with urgently needed…
Read More »

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org